LEADER 04395nam 2200745 a 450 001 9910781413003321 005 20230120064355.0 010 $a1-4696-1387-5 010 $a1-4696-0254-7 035 $a(CKB)2550000000073282 035 $a(EBL)819540 035 $a(OCoLC)769265997 035 $a(SSID)ssj0000551167 035 $a(PQKBManifestationID)11379982 035 $a(PQKBTitleCode)TC0000551167 035 $a(PQKBWorkID)10524495 035 $a(PQKB)10623418 035 $a(StDuBDS)EDZ0000865149 035 $a(MdBmJHUP)muse30308 035 $a(Au-PeEL)EBL819540 035 $a(CaPaEBR)ebr10518910 035 $a(MiAaPQ)EBC819540 035 $a(MiAaPQ)EBC4321984 035 $a(EXLCZ)992550000000073282 100 $a20110420d2011 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 10$aDefending white democracy$b[electronic resource] $ethe making of a segregationist movement and the remaking of racial politics, 1936-1965 /$fJason Morgan Ward 210 $aChapel Hill, N.C. $cUniversity of North Carolina Press$d2011 215 $a1 online resource (265 p.) 300 $aDescription based upon print version of record. 311 $a0-8078-3513-7 311 $a0-8078-6922-8 320 $aIncludes bibliographical references and index. 327 $aAgitating falsely the race problem -- The white south's "double V" -- From white supremacists to "segregationists" -- Nationalizing race and southernizing freedom -- The rhetoric of responsible resistance -- The southern "minority" and the silent majority. 330 $a"After the Supreme Court ruled school segregation unconstitutional in 1954, southern white backlash seemed to explode overnight. Journalists profiled the rise of a segregationist movement committed to preserving the "southern way of life" through a campaign of massive resistance. In Defending White Democracy, Jason Morgan Ward reconsiders the origins of this white resistance, arguing that southern conservatives began mobilizing against civil rights some years earlier, in the era before World War II, when the New Deal politics of the mid-1930s threatened the monopoly on power that whites held in the South. As Ward shows, years before "segregationist" became a badge of honor for civil rights opponents, many white southerners resisted racial change at every turn--launching a preemptive campaign aimed at preserving a social order that they saw as under siege. By the time of the Brown decision, segregationists had amassed an arsenal of tested tactics and arguments to deploy against the civil rights movement in the coming battles. Connecting the racial controversies of the New Deal era to the more familiar confrontations of the 1950s and 1960s, Ward uncovers a parallel history of segregationist opposition that mirrors the new focus on the long civil rights movement and raises troubling questions about the enduring influence of segregation's defenders. "--$cProvided by publisher. 606 $aSegregation$zSouthern States$xHistory$y20th century 606 $aSegregation$xPolitical aspects$zSouthern States$xHistory$y20th century 606 $aWhite people$zSouthern States$xPolitics and government$y20th century 606 $aWhite people$zSouthern States$xAttitudes$xHistory$y20th century 606 $aAfrican Americans$xSegregation$zSouthern States$xHistory 606 $aCivil rights$zSouthern States$xHistory$y20th century 606 $aGovernment, Resistance to$zSouthern States$xHistory$y20th century 607 $aSouthern States$xRace relations$xHistory$y20th century 607 $aSouthern States$xRace relations$xPolitical aspects$xHistory$y20th century 615 0$aSegregation$xHistory 615 0$aSegregation$xPolitical aspects$xHistory 615 0$aWhite people$xPolitics and government 615 0$aWhite people$xAttitudes$xHistory 615 0$aAfrican Americans$xSegregation$xHistory. 615 0$aCivil rights$xHistory 615 0$aGovernment, Resistance to$xHistory 676 $a305.800975 686 $aSOC001000$aSOC031000$aHIS036060$2bisacsh 700 $aWard$b Jason Morgan$01514984 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910781413003321 996 $aDefending white democracy$93750482 997 $aUNINA LEADER 05397nam 2200709 450 001 9910831057703321 005 20230725053506.0 010 $a1-118-08558-2 010 $a1-283-27294-6 010 $a9786613272942 010 $a1-118-26651-X 010 $a0-470-94991-0 010 $a1-118-08559-0 035 $a(CKB)2550000000054520 035 $a(EBL)661580 035 $a(SSID)ssj0000590560 035 $a(PQKBManifestationID)11426917 035 $a(PQKBTitleCode)TC0000590560 035 $a(PQKBWorkID)10665904 035 $a(PQKB)10711156 035 $a(MiAaPQ)EBC3422109 035 $a(MiAaPQ)EBC661580 035 $a(Au-PeEL)EBL661580 035 $a(OCoLC)773301873 035 $a(EXLCZ)992550000000054520 100 $a20160504h20112011 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 14$aThe fund industry $ehow your money is managed /$fRobert Pozen and Theresa Hamacher 205 $a1st ed. 210 1$aHoboken, New Jersey :$cJohn Wiley & Sons, Inc.,$d2011. 210 4$dİ2011 215 $a1 online resource (546 p.) 225 1 $aWiley finance 300 $a"A Wiley Global Finance Executive Selection." 311 $a0-470-63425-1 327 $aThe Fund Industry: How Your Money Is Managed; Contents; Foreword; Preface; Acknowledgments; SECTION One An Investor's Guide to Mutual Funds; CHAPTER 1 Investing through Mutual Funds; ADVANTAGES AND DISADVANTAGES OF MUTUAL FUNDS; HISTORY AND GROWTH; Early History; The Surge in Growth in the 1980s and 1990s; Mutual Fund Ownership in the United States Today; REGULATORS AND INDUSTRY ASSOCIATIONS; Securities and Exchange Commission; FINRA; Department of Labor; State Regulators; Investment Company Institute; NICSA; CHAPTER SUMMARY; CHAPTER 2 How Mutual Funds Work; BUYING AND SELLING FUND SHARES 327 $aTHE PASS-THROUGH TAX STATUS OF MUTUAL FUNDSA VIRTUAL CORPORATION; ETHICAL STANDARDS; ALTERNATIVES TO MUTUAL FUNDS; Direct Investing through Individual Accounts; Other Commingled Investment Vehicles; CHAPTER SUMMARY; CHAPTER 3 Researching Funds: The User Guides; MUTUAL FUNDS AND DISCLOSURE; THE SUMMARY PROSPECTUS; BEYOND THE SUMMARY PROSPECTUS; Prospectus; Statement of Additional Information; Shareholder Reports; USING THE USER GUIDES; CHAPTER SUMMARY; CHAPTER 4 Comparing Mutual Funds; DELINEATING YOUR OWN INVESTMENT OBJECTIVES; EVALUATING PERFORMANCE; THE TAXONOMY OF MUTUAL FUNDS 327 $aMoney Market FundsBond Funds; Stock Funds; Hybrid Funds; CHAPTER SUMMARY; SECTION Two Mutual Fund Portfolio Management; CHAPTER 5 Portfolio Management of Stock Funds; STOCK RESEARCH; Fundamental Research; Valuation; Quantitative Research; PUTTING IT ALL TOGETHER: MANAGING A STOCK FUND; Passive Portfolio Management; Active Portfolio Management; Portfolio Construction; Risk Management; Performance Analysis; CHAPTER SUMMARY; CHAPTER 6 Portfolio Management of Bond Funds; BOND FUND HOLDINGS; Holdings in Taxable Bond Funds; Holdings in Tax-Exempt Funds; PUTTING IT ALL TOGETHER: MANAGING A BOND FUND 327 $aInvestment StrategyPortfolio Construction; CHAPTER SUMMARY; Appendix to Chapter 6: Bond Basics; DEFINING CHARACTERISTICS OF BONDS; KEY ANALYTICAL MEASURES; RISKS OF BOND INVESTMENTS; CHAPTER 7 Portfolio Management of Money Market Funds; HOW-EXACTLY-THE 1.00 NAV WORKS; MONEY MARKET FUND HOLDINGS; Holdings in Taxable Funds; Holdings in Tax-Exempt Funds; PUTTING IT ALL TOGETHER: MANAGING A MONEY MARKET FUND; Research; Trading; Portfolio Management; MONEY MARKET FUNDS AND THE FINANCIAL SYSTEM; CHAPTER SUMMARY; CHAPTER 8 Implementing Portfolio Decisions: Buying and Selling Investments 327 $aTHE IMPORTANCE OF TRADINGTHE EVOLUTION OF THE U.S. STOCK MARKETS; The Traditional Venues; The New Entrants: Alternative Trading Systems; The Convergence of the Old and the New; THE ROLE OF THE MUTUAL FUND TRADER; Fund Compliance; Trading Strategy; Broker-Dealer Selection; Trading Across Multiple Funds; TRADING IN BOND FUNDS; CHAPTER SUMMARY; CHAPTER 9 Mutual Funds as Institutional Investors; MUTUAL FUNDS AS STOCKHOLDERS AND THE PROXY VOTING PROCESS; The Role of Stockholders; The Proxy Voting Process: Stockholder Meetings; PROXY VOTING BY MUTUAL FUNDS; Proxy Voting Policies 327 $aProxy Decision Making 330 $aEvery investor, student of finance and participant in the mutual fund industry needs to read this book The Fund Industry details how mutual funds are marketed, regulated, and invested in stocks and bonds. The book also describes the critical factors needed to choose a specific fund for your investment or retirement plan, including what to look for when reading prospectuses, shareholder reports and third party reviews. In addition, the book: Discusses the spread of mutual funds to Asia, Europe, and Latin AmericaCompares mutual funds to other investment vehicles such as hedge 410 0$aWiley finance series. 606 $aMutual funds$zUnited States 606 $aMutual funds 615 0$aMutual funds 615 0$aMutual funds. 676 $a332.63/27 676 $a332.6327 700 $aPozen$b Robert C.$0247185 702 $aHamacher$b Theresa 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910831057703321 996 $aThe fund industry$94028057 997 $aUNINA LEADER 04456nam 22007095 450 001 9910298277503321 005 20200702164347.0 010 $a94-017-9753-6 024 7 $a10.1007/978-94-017-9753-5 035 $a(CKB)3710000000379462 035 $a(EBL)3109152 035 $a(SSID)ssj0001465040 035 $a(PQKBManifestationID)11755341 035 $a(PQKBTitleCode)TC0001465040 035 $a(PQKBWorkID)11459993 035 $a(PQKB)11397289 035 $a(DE-He213)978-94-017-9753-5 035 $a(MiAaPQ)EBC3109152 035 $a(PPN)184893704 035 $a(EXLCZ)993710000000379462 100 $a20150327d2015 u| 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aSingle Cell Sequencing and Systems Immunology /$fedited by Xiangdong Wang 205 $a1st ed. 2015. 210 1$aDordrecht :$cSpringer Netherlands :$cImprint: Springer,$d2015. 215 $a1 online resource (184 p.) 225 1 $aTranslational Bioinformatics,$x2213-2775 ;$v5 300 $aDescription based upon print version of record. 311 $a94-017-9752-8 320 $aIncludes bibliographical references at the end of each chapters. 327 $aPreface -- Significance of Single Cell Sequencing in Future Medicine -- Uncovering Phenotypes with Supercells: Applications to Single-Cell Sequencing -- Single-Cell Sequencing of Microorganisms -- Application of single-cell sequencing in dynamic transcriptomes -- System Immunology in Metabolic Research of Dendritic Cells -- FOXP3+ Treg Cells and Systems Biology Approaches to Studying Their Function -- ??T Cells and ??T Cells -- Prolymphocyte: Lymphocytes and Bioinformatics -- Lymphocytes in liver cancer -- Early biomarkers of hepatocyte necrosis -- Protocol of Single Cell Isolation by Flow Cytometry -- Single-cell based omics-the new era of human disease and medicine -- Cancer bioinformatics.         . 330 $aThe volume focuses on the genomics, proteomics, metabolomics, and bioinformatics of a single cell, especially lymphocytes and on understanding the molecular mechanisms of systems immunology. Based on the author?s personal experience, it provides revealing insights into the potential applications, significance, workflow, comparison, future perspectives and challenges of single-cell sequencing for identifying and developing disease-specific biomarkers in order to understand the biological function, activation and dysfunction of single cells and lymphocytes and to explore their functional roles and responses to therapies. It also provides detailed information on individual subgroups of lymphocytes, including cell characters, function, surface markers, receptor function, intracellular signals and pathways, production of inflammatory mediators, nuclear receptors and factors, omics, sequencing, disease-specific biomarkers, bioinformatics, networks and dynamic networks, their role in disease and future prospects.   Dr. Xiangdong Wang is a Professor of Medicine, Director of Shanghai Institute of Clinical Bioinformatics, Director of Fudan University Center for Clinical Bioinformatics, Director of the Biomedical Research Center of Zhongshan Hospital, Deputy Director of Shanghai Respiratory Research Institute, Shanghai, China.  . 410 0$aTranslational Bioinformatics,$x2213-2775 ;$v5 606 $aImmunology 606 $aSystems biology 606 $aProteomics 606 $aCytology 606 $aImmunology$3https://scigraph.springernature.com/ontologies/product-market-codes/B14000 606 $aSystems Biology$3https://scigraph.springernature.com/ontologies/product-market-codes/L15010 606 $aProteomics$3https://scigraph.springernature.com/ontologies/product-market-codes/L1403X 606 $aCell Biology$3https://scigraph.springernature.com/ontologies/product-market-codes/L16008 615 0$aImmunology. 615 0$aSystems biology. 615 0$aProteomics. 615 0$aCytology. 615 14$aImmunology. 615 24$aSystems Biology. 615 24$aProteomics. 615 24$aCell Biology. 676 $a616.0790285 702 $aWang$b Xiangdong$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910298277503321 996 $aSingle Cell Sequencing and Systems Immunology$92513403 997 $aUNINA LEADER 04032nam 22005655 450 001 9910163117103321 005 20200706031316.0 010 $a3-319-50409-6 024 7 $a10.1007/978-3-319-50409-4 035 $a(CKB)3710000001045575 035 $a(DE-He213)978-3-319-50409-4 035 $a(MiAaPQ)EBC4799373 035 $a(PPN)198873255 035 $a(EXLCZ)993710000001045575 100 $a20170203d2017 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aCandida albicans: Cellular and Molecular Biology /$fedited by Rajendra Prasad 205 $a2nd ed. 2017. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2017. 215 $a1 online resource (XII, 554 p. 60 illus., 30 illus. in color.) 311 $a3-319-50408-8 320 $aIncludes bibliographical references at the end of each chapters. 327 $aFungal infections -- Fungal infections- The South-Asian perspective -- Regulatory pathways during C. albicans infections -- Virulence mechanisms and regulation -- Signalling mechanisms in pathogenesis and virulence of C. albicans -- Biofilm development -- Biofilm development and resistance mechanisms -- Biofilm of C. albicans: development and regulation -- Host immune responses during infections -- Mechanism of drug resistance -- Structure- function analyses of Multi-drug transporters -- All about MFS multi-drug transporter of Candida albicans -- Inhibitors/Modulators of MDR transporters -- Inhibitors/Modulators of MDR proteins/transporters -- Anti-fungals -- Anti-microbial peptides -- Anti-candidial agents -- MDR1 and its regulation -- Genomics and Anti-fungal resistance -- Genomics and Anti-fungal resistance -- Lipids and Multi-drug resistance in Candida albicans -- Cell wall of Candida albicans and its role in virulence -- Hyphal morphogenesis of C. albicans -- Innate immune defences against fungal infections. 330 $aThis book on Candida albicans and similar pathogens provides a timely overview of the groundbreaking discoveries made in the areas of drug resistance, host?pathogen interactions, virulence, host immune system modulation, etc., in the last two decades. This comprehensive 2nd Edition includes chapters on fungal infections, hyphal morphogenesis, molecular mechanisms of antifungal resistance, antifungal agents, multidrug transporters, virulence mechanisms in Candida albicans, host?pathogen interactions, the cell wall, fungal biofilms, lipids and antifungal resistance, signaling mechanisms and last but not the least host-immune responses. As such, it offers an ideal reference guide for mycologists, researchers, pharmacists, clinicians, and undergraduate students engaged or interested in fungal research. It will also benefit clinicians, who are required to keep abreast of the current state of research on antifungal drug resistance and antifungal development. 606 $aMycology 606 $aMolecular biology 606 $aDrug resistance 606 $aCell membranes 606 $aMycology$3https://scigraph.springernature.com/ontologies/product-market-codes/L27000 606 $aMolecular Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/B1700X 606 $aDrug Resistance$3https://scigraph.springernature.com/ontologies/product-market-codes/B16020 606 $aMembrane Biology$3https://scigraph.springernature.com/ontologies/product-market-codes/L16050 615 0$aMycology. 615 0$aMolecular biology. 615 0$aDrug resistance. 615 0$aCell membranes. 615 14$aMycology. 615 24$aMolecular Medicine. 615 24$aDrug Resistance. 615 24$aMembrane Biology. 676 $a579.135 702 $aPrasad$b Rajendra$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910163117103321 996 $aCandida albicans: Cellular and Molecular Biology$92266522 997 $aUNINA